Skip to Content Facebook Feature Image

China, Myanmar strengthen agricultural ties through research, trade

China

China

China

China, Myanmar strengthen agricultural ties through research, trade

2026-06-18 16:39 Last Updated At:17:37

Agriculture is emerging as one of the strongest pillars of China-Myanmar relations, with joint research, talent exchanges and expanding trade driving the partnership forward.

In southwest China's Yunnan Province, researchers from both countries are working side by side to boost innovation and productivity in key crop sectors.

Myanmar's researcher April Nwet Yee Soe is spending a year at the Yunnan Academy of Agricultural Sciences, studying biological control methods for sugarcane diseases.

"In the sugarcane area and other areas, China is very advanced. And I think if I come here and learn some advanced technologies, then after I come back, I can contribute to my community and my country," she said.

Sugarcane is one of Myanmar's major cash crops and an important source of income for many families. For the country's agricultural botanists, research done in Yunnan on sugarcane presents a valuable opportunity for collaboration, as well as the start of a longer scientific journey.

"Now, I am finding the pathogenic fungi from sugarcane smut-infected plants. And then, after I get the pathogenic fungi, I will go do the molecular work for biocontrol," April said.

April's research builds on years of agricultural cooperation between China and Myanmar. Since 2008, the academy has worked with Myanmar partners on sugarcane breeding, cultivation techniques and technology transfer.

"Through the introduction of our sugarcane varieties and cultivation techniques, average sugarcane yields in Myanmar have increased from 3.8 to 4.5 tonnes per mu (about to 57 to 67 tonnes per hectare)," said Zhao Yong, director of the Agronomy Center at the Sugarcane Research Institute under the Yunnan Academy of Agricultural Sciences.

Higher yields have also strengthened agricultural trade. During the 2025-26 sugarcane crushing season, Myanmar exported more than 2 million tonnes of sugarcane to Yunnan, creating jobs in Myanmar while supporting for China's sugar industry. Cooperation has since expanded to upland rice, soybeans and tropical fruits, covering the entire agricultural value chain from breeding to quality testing.

Talent exchange remains at the heart of the partnership. The academy has hosted 14 Myanmar researchers and sent nearly 40 Chinese experts to Myanmar. The next focus is to build capacity in agricultural standards and quality testing, according to the Chinese side.

"Through the standardized system for agricultural product quality testing, we aim to enhance the capacity of young Myanmar scientists in building such standards. With this improvement, agricultural products from China and Myanmar will be able to achieve mutual recognition, facilitating trade between the two sides," said Wang Zhiyuan, director of the academy's International Cooperation Department.

President of Myanmar Min Aung Hlaing is on a state visit to China from June 15 to 19, at the invitation of Chinese President Xi Jinping, putting agricultural cooperation between the two sides once again in the spotlight.

China, Myanmar strengthen agricultural ties through research, trade

China, Myanmar strengthen agricultural ties through research, trade

Danish pharmaceutical giant Novo Nordisk has announced plans to invest another 200 million yuan (about 29.6 million U.S. dollars) to expand its production lines in north China's Tianjin.

Sprawling across 220,000 square meters inside the Tianjin Economic-Technological Development Area, the Novo Nordisk Tianjin production site is one of the company's strategic global manufacturing hubs, supplying injection devices and finished pharmaceutical products to China and other markets.

The site has launched several expansion projects in recent years, steadily stepping up the production hub's capacity.

In an interview with China Central Television (CCTV), Novo Nordisk's president and CEO Mike Doustdar said the company is bullish on China's technological strength and market prospects, stressing its accelerated pace of investment in China in recent years.

"We just made a new announcement of extending the factory with another investment of 200 million yuan. Since 2003, we have invested 17 billion yuan and since 2023, we have invested 6 billion yuan. Sixty percent of the manufacturing basically goes to consumption here in China. Forty percent of the production is exported to the rest of the world," said Doustdar.

Beyond expanding production lines, Novo Nordisk also launched China Essentials, an innovation-support program, back in 2020, making it one of the first multinational pharmaceutical companies to carry out localized research and development and manufacturing in China.

The move reflects a broader shift. In recent years, many pharmaceutical companies have not limited themselves to setting up factories in China, rather, they have pivoted toward deeper research and development collaboration with local companies.

"I see it increasingly as fascinating and something the world cannot ignore. Forty-four percent of all new chemical entities that are introduced are actually made in China. Just a couple of years back, it was less than 30 percent. So it's really rapidly increasing," said Doustdar.

According to a report from Bloomberg, cooperation between Chinese and foreign pharmaceutical companies has seen explosive growth since 2026. As of the end of March this year, Chinese pharmaceutical companies accounted for 55 percent of global licensing deals, up from less than 10 percent in 2021.

The numbers show that China is no longer just a market where multinationals hope to sell their products. It is becoming a powerhouse to partner with and emerging as a key player in global pharmaceutical innovation.

Novo Nordisk ramps up investment in China, highlighting country's technological strengths

Novo Nordisk ramps up investment in China, highlighting country's technological strengths

Recommended Articles